XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022   109,871      
Beginning balance at Dec. 31, 2022 $ 324,506 $ 110 $ 2,380,651 $ (2,046,569) $ (9,686)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 6,648     6,648  
Other comprehensive loss, net of tax 2,723       2,723
Issuance of common stock under stock option, award and purchase plans, net (in shares)   1,713      
Issuance of common stock under stock option, award and purchase plans, net (4,559) $ 2 (4,561)    
Stock-based compensation $ 13,483   13,483    
Issuance of common stock upon conversion of 2024 Notes (in shares) 0        
Ending balance (in shares) at Jun. 30, 2023   111,584      
Ending balance at Jun. 30, 2023 $ 342,801 $ 112 2,389,573 (2,039,921) (6,963)
Beginning balance (in shares) at Mar. 31, 2023   111,332      
Beginning balance at Mar. 31, 2023 335,786 $ 111 2,384,806 (2,041,476) (7,655)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 1,555     1,555  
Other comprehensive loss, net of tax 692       692
Issuance of common stock under stock option, award and purchase plans, net (in shares)   252      
Issuance of common stock under stock option, award and purchase plans, net (1,291) $ 1 (1,292)    
Stock-based compensation 6,059   6,059    
Ending balance (in shares) at Jun. 30, 2023   111,584      
Ending balance at Jun. 30, 2023 $ 342,801 $ 112 2,389,573 (2,039,921) (6,963)
Beginning balance (in shares) at Dec. 31, 2023 112,407 112,407      
Beginning balance at Dec. 31, 2023 $ 436,874 $ 112 2,405,043 (1,962,575) (5,706)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (20,621)     (20,621)  
Other comprehensive loss, net of tax (4,421)       (4,421)
Issuance of common stock under stock option, award and purchase plans, net (in shares)   1,422      
Issuance of common stock under stock option, award and purchase plans, net $ (2,710) $ 1 (2,711)    
Repurchase of common stock (in shares) (2,400) (2,409)      
Repurchase of common stock $ (30,049) $ (2)   (30,047)  
Excise tax on share repurchases (90)     (90)  
Stock-based compensation $ 13,877   13,877    
Issuance of common stock upon conversion of 2024 Notes (in shares) 4,578 4,578      
Issuance of common stock upon conversion of 2024 Notes $ (52) $ 5 (57)    
Ending balance (in shares) at Jun. 28, 2024 115,998 115,998      
Ending balance at Jun. 28, 2024 $ 392,808 $ 116 2,416,152 (2,013,333) (10,127)
Beginning balance (in shares) at Mar. 29, 2024   111,946      
Beginning balance at Mar. 29, 2024 409,154 $ 112 2,410,094 (1,992,339) (8,713)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (12,532)     (12,532)  
Other comprehensive loss, net of tax (1,414)       (1,414)
Issuance of common stock under stock option, award and purchase plans, net (in shares)   225      
Issuance of common stock under stock option, award and purchase plans, net (839)   (839)    
Repurchase of common stock (in shares)   (751)      
Repurchase of common stock (8,373) $ (1)   (8,372)  
Excise tax on share repurchases (90)     (90)  
Stock-based compensation 6,954   6,954    
Issuance of common stock upon conversion of 2024 Notes (in shares)   4,578      
Issuance of common stock upon conversion of 2024 Notes $ (52) $ 5 (57)    
Ending balance (in shares) at Jun. 28, 2024 115,998 115,998      
Ending balance at Jun. 28, 2024 $ 392,808 $ 116 $ 2,416,152 $ (2,013,333) $ (10,127)